Streamex Corp.

Streamex Corp. is a U.S.-based medical technology company in the electromedical and electrotherapeutic apparatus field. The company’s reported filings show a corporate structure that has included Streamex Exchange Corporation and related entities, with activities centered on securities issuance, corporate transactions, and the development of its operating platform.

1.68

— Streamex Corp.
	%
Electromedical apparatus	70% Devices and apparatus used for medical electrical or therapeutic applications.
Corporate development and structuring	20% Entity-level transaction work, acquisitions, and financing-related activities.
Equity and warrant-related instruments	10% Stock issuances, warrants, RSUs, and other capital structure instruments.

Streamex’s end users are best understood as healthcare and medical-device market participants that would use or...

Healthcare and medical-device end usersprimary
Buy or use electromedical apparatus for therapeutic or clinical applications.
Distributors and channel partnerssecondary
Acquire products for resale or deployment into medical settings.
Consultants and service providerssecondary
Receive equity or other consideration for advisory and operating services.
Capital markets counterpartiesprimary
Provide financing, warrants, or transaction support tied to corporate actions.

Streamex is headquartered in the United States, and its public filings are reported through a U.S...

•Headquartered in the United States
•SEC-reporting issuer with U.S. capital markets exposure
•No country-level revenue disclosure in the excerpts provided
•Potential cross-border entity structure in corporate transactions
•Geography affects regulatory, financing, and healthcare market access

The company’s disclosures suggest a strategy centered on building and financing its operating platform while using...

Platform development and transaction executionmedium-term

The company appears to rely on corporate actions to build and scale its operating base.

Capital formation and dilution managementshort-term

Equity issuances and warrant exercises are central to funding and ownership structure.

Commercialization of medical technology assetsmedium-term

A medical-device business must convert development assets into marketable products.

Streamex faces the typical risks of an early-stage or development-oriented medical technology company, including...

high

Commercialization and adoption risk

Medical technology products must clear technical, clinical, and market hurdles before scaling.

Scope: Product development and market launch
Materiality: high

high

Dilution from equity-based financing

The company has issued common stock for services, RSUs, and warrant exercises.

Scope: Shareholders and capital structure
Materiality: high

high

Regulatory and legal compliance risk

Electromedical products and SEC-reporting obligations both require strict compliance.

Scope: Medical device approvals and public-company reporting
Materiality: high

medium

Transaction execution risk

Corporate agreements and entity restructuring can fail to deliver expected value.

Scope: M&A and strategic partnerships
Materiality: medium

Stock-based compensation

Affects operating expenses, equity, and diluted share count

Warrants and cashless exercises

Affects equity structure and dilution analysis

Shares issued for services or debt settlement

Affects expense recognition and balance sheet classification

Streamex Corp.

Commercialization and adoption risk

Dilution from equity-based financing

Regulatory and legal compliance risk

Transaction execution risk

IR-Med, Inc.

ENvue Medical, Inc.

Curanex Pharmaceuticals Inc

Cadrenal Therapeutics, Inc.

IRIDEX CORP

Ocean Biomedical, Inc.